Max Smock
Stock Analyst at William Blair
(0.26)
# 4,192
Out of 4,884 analysts
17
Total ratings
20%
Success rate
-23.07%
Average return
Main Sectors:
Stocks Rated by Max Smock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFCR Lifecore Biomedical | Initiates: Outperform | n/a | $8.04 | - | 1 | May 21, 2025 | |
| MEDP Medpace Holdings | Downgrades: Market Perform | n/a | $321.50 | - | 4 | Apr 22, 2025 | |
| FTRE Fortrea Holdings | Reiterates: Market Perform | n/a | $5.22 | - | 5 | Mar 4, 2025 | |
| CRL Charles River Laboratories International | Downgrades: Market Perform | n/a | $157.12 | - | 2 | Jan 22, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | n/a | $150.10 | - | 1 | Jan 14, 2025 | |
| SLP Simulations Plus | Reiterates: Outperform | n/a | $17.75 | - | 4 | Nov 6, 2024 |
Lifecore Biomedical
May 21, 2025
Initiates: Outperform
Price Target: n/a
Current: $8.04
Upside: -
Medpace Holdings
Apr 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $321.50
Upside: -
Fortrea Holdings
Mar 4, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $5.22
Upside: -
Charles River Laboratories International
Jan 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $157.12
Upside: -
ICON Public Limited Company
Jan 14, 2025
Reiterates: Outperform
Price Target: n/a
Current: $150.10
Upside: -
Simulations Plus
Nov 6, 2024
Reiterates: Outperform
Price Target: n/a
Current: $17.75
Upside: -